Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension

Hypertension

Volumn 35, Issue 1 II, 2000, Pages 490-495

  Redon, Josep ^b   Chaves, Felipe Javier ^c   Liao, Youlian ^a   Pascual, Jose Maria ^c   Rovira, Eduardo ^c   Armengod, Maria Eugenia ^c   Cooper, Richard S ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c NONE

Author keywords

Albuminuria; Angiotensin converting enzyme gene; Genetics; Hypertension, essential

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; HYDROCHLOROTHIAZIDE;

ADULT; CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE;

EID: 0033977304     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.35.1.490     Document Type: Conference Paper

References (30)

1. Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens. 1998;16:1325-1333.
2. Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla G, Palombo C, Ghione S. Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens. 1989;2: 259-261.
3. Redon J, Lozano JV, Liao Y, Miralles A, Baldo E, Cooper RS. Factors related to the presence of microalbuminuria in essential hypertension. Am J Hypertens. 1994;7:801-807.
4. Redon J, Miralles A, Pascual JM, Baldó E, Garcia-Robles R, Carmena R. Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension. J Hypertens. 1997;15:79-86.
5. Bianchi S, Bigazzi R, Qiñones A, Muscelli E, Baldari G, Pecori N, Ciociaro D, Ferranini E, Natali A. Insulin resistance in microalbuminuric hypertension: sites and mechanisms. Hypertension. 1995;26:789-795.
6. Pontremoli R, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F, Bezante GP, Borgia L, Babola N, Ravazzolo R, Sacchi G, Deferrari G. The deletion/insertion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol. 1996;7:2550-2558.
7. Yudkin JS, Andres C, Mohamed AV, Gould M, Panahloo A, Haines AP, Humphries S, Talmud P. The angiotensin-converting enzyme gene and the angiotensin II type I receptor gene as a candidate genes for microalbuminuria: a study in nondiabetic and non-insulin-dependent diabetic subjects. Arterioscl Thromb Vasc Biol. 1997;17:2188-2191.
8. Fernandez-Llama P, Poch E, Oriola J, Botey A, Coll E, Darnell A, Rivera F, Revert L. Angiotensin converting enzyme I/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney Int. 1998;53: 1743-1747.
9. Parving H-H, Jacobsen P, Tarnow L, Rossing P, Lacerf L, Potrier O, Cambien F. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetes nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. BMJ. 1996;313:591-594.
10. Stratta P, Canavese C, Ciccone G, Barolo S, Dall'Omo AM, Fasano ME, Mazzola G, Berutti S, Fop F, Curtoni ES, Piccoli G. Angiotensin I-converting enzyme genotype significantly affects progression of IgA glomerulonephritis in an Italian population. Am J Kidney Dis. 1999;33: 1071-1079.
11. van Essen GG, Rensma PL, de Zeew D, Sluiter WJ, Scheffer H, Apperloo AJ, de Jong PE. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet. 1996; 347:94-95.
12. Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F. Effect of deletion polymorphism of angiotensin converting enzyme on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. BMJ. 1996;313:591-594.
13. Tiltzer LL, Thomas SM, Moreno RF. Use of silica gel polymer for DNA extraction with organic solvents. Anal Biochem. 1989;183:13-15.
14. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) dipeptidyl carboxypeptidase 1. Nucleic Acids Res. 1992; 20:1433.
15. Redon J. Renal protection with antihypertensive drugs: insights from the microalbuminuria studies. J Hypertens. 1998;16:2091-2100.
16. Erley CM, Haefele U, Heyne N, Braun N, Risler T. Microalbuminuria in essential hypertension: reduction by different antihypertensive drugs. Hypertension. 1993;21(pt 1):810-815.
17. Ranieri G, Andriani A, Lamontanara G, De Cesaris R. Effects of lisinopril and amlodipine on microalbuminuria and renal function in patients with hypertension. Clin Pharmacol Ther. 1994;56:323-330.
18. Gerber LM, Smukler C, Alderman MH. Differences in urinary albumin excretion rate between normotensive and hypertensive, white and nonwhite subjects. Arch Intern Med. 1992;152:373-377.
19. Redon J, Miralles A, Liao Y, Lozano JV, Pascual JM, Cooper RS. Circadian variability and microalbuminuria in essential hypertension. J Hypertens. 1994;12:947-954.
20. Erley CM, Holzer M, Kramer BK, Risler T. Renal hemodynamics and organ damage in young hypertensive patients with different plasma renin activities after ACE inhibition. Nephrol Dial Transplant. 1992;7: 216-220.
21. Agewall S, Fagerberg B, Attvall S, Ljungman S, Urbanavicius V, Tengborn L, Wikstrand J, on behalf of the Risk Factor Intervention Study Group. Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. J Intern Med. 1995;237:195-203.
22. Staessen J, Wang JG, Ginocchio G, Petrov V, Saavedra A, Soubrier F, Vlietnick R, Fagard R. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens. 1997;15:1579-1592.
23. Rovira E, Chaves FJ, Juive R, Pascual JM, Miralles A, Armengod ME, Redon J. Polymorphism I/D of the angiotensin-converting enzyme gene and microalbuminuria in essential hypertension. Med Clin 1999;112: 726-730. In Spanish.
24. Rigat B, Hubert C, Alhene-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
25. Matsusaka T, Hymes J, Ichikawa Y. Angiotensin in progressive renal diseases: theory and practice. J Am Soc Nephrol. 1996;7:2025-2043.
26. Jeng JR, Shieh SM, Harn HJ, Lee MM, Sheu WH, Jeng CY. Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with hypertension. J Hypertens. 1997;15:963-968.
27. Chiu KC, McCarthy JE. The insertion allele at the angiotensin I-converting enzyme gene locus is associated with insulin resistance. Metabolism. 1997;46:395-399.
28. Townsend RR, DiPette D. Pressor doses of angiotensin II increase insulin-mediated glucose uptake in normotensive men. Am J Physiol. 1993;265:E362-E366.
29. Modification of Diet in Renal Disease Study Group, Hebert L, Kusek JW, Greene T, Agodoa L, Jones CA, Levey AS, Breyer JA, Faubert P, Rolin HA, Wang SR, Writing Group. Effects of blood pressure control on progressive renal disease in blacks and whites. Hypertension. 1997;30(pt I):428-435.
30. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non diabetic nephropathy. Lancet. 1997;349:1857-1863.